Melatonin acts as a chronobiotic agent that helps regulate circadian rhythms and may reduce neurogenic inflammation in cluster headache pathogenesis. By binding to melatonin receptors (MT1 and MT2) in the hypothalamus and modulating neurotransmitter release, it can potentially decrease headache frequency and intensity. Its primary effects include reducing neuronal excitability and providing neuroprotective and anti-inflammatory properties.